183 related articles for article (PubMed ID: 1392324)
1. The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.
Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
Surg Today; 1992; 22(3):213-20. PubMed ID: 1392324
[TBL] [Abstract][Full Text] [Related]
2. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.
Noguchi M; Taniya T; Ohta N; Koyasaki N; Miyazaki I; Mizukami Y
Breast Cancer Res Treat; 1991 Sep; 19(1):23-31. PubMed ID: 1661623
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
[TBL] [Abstract][Full Text] [Related]
5. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
[TBL] [Abstract][Full Text] [Related]
6. Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients.
Noguchi M; Ohta N; Thomas M; Kitagawa H; Miyazaki I
J Surg Oncol; 1993 Jan; 52(1):26-30. PubMed ID: 8441257
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy and helix pomatia lectin binding as predictors of regional lymph node metastases and prognostic factors in breast cancer.
Noguchi M; Thomas M; Kitagawa H; Kinishita K; Kinami S; Takamura H; Miyazaki I; Mizukami Y
Breast Cancer Res Treat; 1993; 26(1):67-75. PubMed ID: 7691268
[TBL] [Abstract][Full Text] [Related]
8. C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Cancer; 1992 Jun; 69(12):2953-60. PubMed ID: 1350504
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study on the clinical and biological prediction of axillary lymph node metastasis in breast cancer.
Noguchi M; Ohta N; Thomas M; Kitagawa H; Earashi M; Miyazaki I; Mizukami Y
Surg Today; 1993; 23(7):573-9. PubMed ID: 8103689
[TBL] [Abstract][Full Text] [Related]
10. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
11. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
12. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.
Janni W; Rack B; Sommer H; Schmidt M; Strobl B; Rjosk D; Klanner E; Thieleke W; Gerber B; Friese K; Dimpfl T
J Cancer Res Clin Oncol; 2003 Sep; 129(9):503-10. PubMed ID: 12884027
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer.
Gasparini G; Meli S; Panizzoni GA; Visonà A; Boracchi P; Bevilacqua P; Marubini E; Pozza F
Breast Cancer Res Treat; 1992 Mar; 20(3):195-204. PubMed ID: 1571572
[TBL] [Abstract][Full Text] [Related]
14. A multivariate study of the relationship between regional lymph node metastases and prognosis in patients with operable breast cancer.
Noguchi M; Taniya T; Koyasaki N; Ohta N; Miyazaki I
Jpn J Surg; 1991 Nov; 21(6):613-20. PubMed ID: 1664901
[TBL] [Abstract][Full Text] [Related]
15. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
16. Prognostic studies in breast cancer. Multivariate combination of nodal status, proliferation index, tumor size, and DNA ploidy.
Collan YU; Eskelinen MJ; Nordling SA; Lipponen P; Pesonen E; Kumpusalo LM; Pajarinen P; Kettunen KO
Acta Oncol; 1994; 33(8):873-8. PubMed ID: 7818918
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between extranodal invasion in axillary lymph node metastasis and prognosis of breast cancer patients].
Zhang LL; Ma L; Geng CZ; Jia Y; Wang XL; Liu YP
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):525-529. PubMed ID: 28810291
[No Abstract] [Full Text] [Related]
18. Prognostic Significance of Tumor-Positive Internal Mammary Sentinel Lymph Nodes in Breast Cancer: A Multicenter Cohort Study.
Madsen EV; Aalders KC; van der Heiden-van der Loo M; Gobardhan PD; van Oort PM; van der Ent FW; Rutgers EJ; Valdés Olmes RA; Elias SG; van Dalen T
Ann Surg Oncol; 2015 Dec; 22(13):4254-62. PubMed ID: 25808100
[TBL] [Abstract][Full Text] [Related]
19. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
20. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
